Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-56

A great post (again) Hottod. Thanks.

These results look more impressive than the Retts results (which is in line with the mouse testing). But this result also helps to confirm the Retts results too.

The market is a funny thing. A bad result and they would instantly be smashed down. A good result and they don't rise that much on the first day.

But the future is bright. In fact the chance of a deal or takeover is right on the cards now. They have always said no deal until after the phase 2's.

We still have the massive TBI result to come too. This is a bit less risky now because even if they fail in that trial they still have success in Retts and Fragile X (both ends of the autistic spectrum).

However I'm thinking we will see success in the TBI trial too. The efficacy is much more immediate, the drug dose higher, a huge number of participants and no real possibility of a placebo effect.

Hold on tight to your shares (sung to ELO's tune).

Cheers